FDA Not Ready for Innovation Guidance Yet, Acting Commissioner Says
May 4, 2021
Decentralized clinical trials are here to stay, but the FDA won’t be ready to move forward with more formal recommendations until the pandemic is over, according to Acting Commissioner Janet Woodcock.